HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Mary Kay's Daily Benefits is company's first foray into nutritional supplement market.

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

MARY KAY ENTERS NUTRITIONAL SUPPLEMENT MARKET WITH DAILY BENEFITS, a regimen of six vitamin and mineral supplements "developed to meet a woman's special needs." Containing 24 vitamins and minerals, the Daily Benefits regimen includes a multivitamin tablet with minerals, two antioxidant softgels, a B-complex tablet with calcium, a magnesium tablet and a calcium tablet.

Table

View full table

Tags:
Latest Headlines

AI News: Lauder Expands Microsoft Partnership; Prose Beauty; Supply Chain Software; More

Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs

Haleon Capitalizes On Global Rebound Of Dietary Supplement Sales

Chanelle McCoy, Cannaray First To Pass UK FSA’s CBD Safety Assessment

See All
UsernamePublicRestriction

Register

RS001832

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By